Global Endoprosthesis Market-Forecast till 2027

$4450$6250

The global endoprosthesis market is anticipated to witness a healthy CAGR of 11.50% during the review period.

SKU: MRFR210212 Category: Tag:

Description

Global Endoprosthesis Market-Forecast till 2027

Endoprosthesis Market Overview

The global endoprosthesis market is anticipated to witness a healthy CAGR of 11.50% during the review period. Endoprosthesis is a treatment that includes utilizing an embed to supplant a joint in the body that has lost working capacities because of harm or disease. Degenerative joint sickness, cracks, and malignancies are for the most part normal signs that an endoprosthesis ought to be utilized.

The global endoprosthesis market accounted for USD 20,679.25 million in 2020 and is estimated to surpass USD 45,134.19 million by 2027. The expansion of the global endoprosthesis market is attributed to the elements like the expanding pervasiveness of osteoarthritis among the geriatric populace, mechanical headways in endoprosthesis gadgets empowering successful treatment, and expanding mindfulness among the populace.

Besides, unfavourable impacts and significant expenses related to endoprosthesis and lack of healthcare infrastructure and unaffordability in emerging countries are set to limit the endoprosthesis market development in the future.

Market Segmentation

The global endoprosthesis market based on products has been classified as knee, Hip, Shoulder, Elbow, Finger or Hand, and Ancle or foot.
Based on product segment, the global market is segmented into the knee, hip, shoulder, elbow, finger/hand, and ankle/foot.

The knee segment is further classified into primary knee replacement, partial knee replacement, custom-made replacements, revision knee replacement, and tumor.

By hip segment, the global endoprosthesis market is segmented into primary hip replacement, partial hip replacement, revision hip replacement, tumor, and custom-made partial pelvic replacements.

Based on the shoulder, the global endoprosthesis market is dispersed into primary shoulder replacement, revision shoulder replacements, tumor, and custom-made replacements.

In terms of the elbow, the global endoprosthesis market is segregated into total elbow replacement, radial head replacement, tumor, and custom-made replacements.
By finger/hand, the global endoprosthesis market is classified into total wrist prosthesis, (Proximal Interphalangeal) PIP finger prosthesis, and Metacarpophalangeal (MCP) finger prosthesis.

In terms of ankle/foot, the global endoprosthesis market is divided into total ankle implant and great toe implant.

Regional Analysis

North America held the largest market share in 2020. In North America, the endoprosthesis market is driven by the expanding reception of in fact progressed medical care items in the region and rising joint inflammation cases.

As indicated by the information distributed in the Centers for Disease Control and Prevention (CDC), the extended commonness of US grown-ups who are relied upon to report specialist analyzed joint pain is 67 million of every 2020, and by 2030, the number is projected to arrive at 72 million.

Accordingly, the district will request a compelling endoprosthesis gadget to conquer this sickness trouble. This factor is additionally projected to drive market development.

South America has seen extensive development in the endoprosthesis market and held a portion of the overall industry of 14.6% in 2020. Across South America, endoprosthesis rehearses are completed in various clinical offices, for example, government-controlled research facilities.

Monetarily autonomous patients frequently pick private research facility treatment. Brazil is one of the significant nations involving the biggest portion of the overall industry in the South American endoprosthesis market.

Prominent Players

The Major Companies Covered in this Report are Johnson & JohnsonServices, Inc.(US), Zimmer Biomet HoldingsInc.(US), Stryker(US), Smith & Nephew (UK), CorinLtd(UK), MedactaInternational SA(Switzerland), Exactech, Inc.(US), MicroPortOrthopedics,Inc.(US), A. (Switzerland), BraunMelsungenAG (Germany), Total Ankle Replacement (STAR; Small Bone Innovations, Morrisville, US), INBONE (Wright Medical Technology, Arlington, US),

Agility (DePuy, Warsaw, US), and Salto Talaris (Tornier, Montbonnot, France).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.

Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Growing public awareness, and technological advancements in endoprosthesis devices are anticipated to fuel the growth of the global endoprosthesis market at a CAGR of 11.58% during the forecast period of 2021 to 2027

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF OSTEOARTHRITIS AMONG THE GERIATRIC POPULATION

4.2.2 INCREASED INCIDENCES OF BONE FRACTURES

4.2.3 TECHNOLOGICAL ADVANCEMENTS IN ENDOPROSTHESIS DEVICES ENABLING EFFECTIVE TREATMENT

4.2.4 GROWING AWARENESS AMONG POPULATION

4.3 RESTRAINTS

4.3.1 ADVERSE EFFECTS ASSOCIATED WITH ENDOPROSTHESIS POST SURGERY

4.3.2 LACK OF HEALTHCARE INFRASTRUCTURE AND UNAFFORDABILITY IN EMERGING COUNTRIES

4.3.3 RESTRAINT IMPACT ANALYSIS

4.4 OPPORTUNITIES

4.4.1 RISING R&D INVESTMENTS FOR ENDOPROSTHESIS

4.4.2 INCREASING NUMBER OF PRODUCT LAUNCH, MERGER & ACQUISITION, AND EXPANSION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE ENDOPROSTHESIS MARKET

5.3.1 OVERVIEW

5.3.2 IMPACT ON SUPPLY CHAIN

5.3.3 IMPACT ON MARKET

5.3.4 DEMAND-SUPPLY GAP ANALYSIS

6 GLOBAL ENDOPROSTHESIS MARKET BY PRODUCT

6.1 OVERVIEW

6.2 KNEE

6.3 HIP

6.4 SHOULDER

6.5 ELBOW

6.6 FINGER/HAND

6.7 ANKLE/FOOT

7 GLOBAL ENDOPROSTHESIS MARKET BY KNEE

7.1 OVERVIEW

7.2 PRIMARY KNEE REPLACEMENT

7.2.1 PRIMARY CEMENTED KNEE REPLACEMENT

7.2.2 PRIMARY CEMENTLESS KNEE REPLACEMENT

7.2.3 PRIMARY HYBRID KNEE REPLACEMENT

7.2.4 BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT

7.2.4.1 PATELLA RESURFACING

7.2.4.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT

7.2.4.3 UNCOATED KNEE REPLACEMENT

7.2.4.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)

7.2.5 MOBILE-BEARING

7.2.6 FIXED-BEARING

7.2.6.1 FIXED-BEARING WITH CEMENTED STEM

7.2.6.2 OTHERS

7.2.7 POSTERIOR STABILIZED

7.2.8 CRUCIATE-RETAINING

7.2.8.1 ULTRA-CONGRUENT OR CRUCIATE SUBSTITUTING

7.2.8.2 LATERAL PIVOT

7.2.8.3 MEDIAL PIVOT

7.3 PARTIAL KNEE REPLACEMENT

7.3.1 UNICOMPARTMENTAL PARTIAL KNEE REPLACEMENT

7.3.2 BICOMPARTMENTAL PARTIAL KNEE REPLACEMENT

7.3.3 PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT

7.3.3.1 PATELLA RESURFACING

7.3.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT

7.3.3.3 UNCOATED KNEE REPLACEMENT

7.3.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)

7.4 REVISION KNEE REPLACEMENT

7.4.1 COMPLETE NON-HINGED REVISION KNEE REPLACEMENT

7.4.2 COMPLETE HINGED REVISION KNEE REPLACEMENT

7.4.3 PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT

7.4.3.1 PATELLA RESURFACING

7.4.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT

7.4.3.3 UNCOATED KNEE REPLACEMENT

7.4.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)

7.4.3.5 DEFECT FILLER (METAPHYSEAL)

7.5 TUMOR

7.5.1 PROXIMAL TIBIA REPLACEMENT

7.5.2 DISTAL FEMUR REPLACEMENT

7.6 CUSTOM MADE REPLACEMENT

7.6.1 GROWING PROSTHESIS

8 GLOBAL ENDOPROSTHESIS MARKET BY HIP

8.1 OVERVIEW

8.2 PRIMARY HIP REPLACEMENT

8.2.1 PRIMARY CEMENTED HIP REPLACEMENT

8.2.2 PRIMARY CEMENTLESS HIP REPLACEMENT

8.2.3 PRIMARY HYBRID HIP REPLACEMENT

8.2.3.1 DUAL MOBILITY CUP CEMENTED

8.2.3.2 DUAL MOBILITY CUP CEMENTLESS

8.2.4 HIP RESURFACING

8.2.5 TOTAL HIP RESURFACING

8.2.6 HEMI HIP RESURFACING

8.3 PARTIAL HIP REPLACEMENT

8.3.1 BIPOLAR PARTIAL HIP REPLACEMENT

8.3.2 UNIPOLAR PARTIAL HIP REPLACEMENT

8.3.3 ONE-PIECE ENDOPROSTHESIS PARTIAL HIP REPLACEMENT

8.4 CUSTOM HIP REPLACEMENTS

8.5 REVISION HIP REPLACEMENT

8.5.1 COMPLETE HIP REVISION

8.5.1.1 COMPLETE HIP REVISION WITH DUAL MOBILITY CUP

8.5.2 ACETABULAR COMPONENT REVISION

8.5.2.1 ACETABULAR COMPONENT REVISION WITH DUAL MOBILITY CUP

8.5.3 FEMORAL STEM REVISION

8.5.4 OTHER HIP REVISION

8.6 TUMOR

8.6.1 PROXIMAL FEMUR REPLACEMENT

9 GLOBAL ENDOPROSTHESIS MARKET BY SHOULDER

9.1 OVERVIEW

9.2 PRIMARY SHOULDER REPLACEMENT

9.2.1 PARTIAL SHOULDER REPLACEMENT

9.2.2 TOTAL/PRIMARY SHOULDER REPLACEMENT

9.2.3 REVERSE SHOULDER REPLACEMENT

9.2.4 SHOULDER RESURFACING

9.3 REVISION SHOULDER REPLACEMENTS

9.4 TUMOR

9.4.1 PROXIMAL HUMERUS REPLACEMENT

9.5 CUSTOM MADE REPLACEMENTS

10 GLOBAL ENDOPROSTHESIS MARKET BY ELBOW

10.1 OVERVIEW

10.2 TOTAL ELBOW REPLACEMENT

10.3 RADIAL HEAD REPLACEMENT

10.4 TUMOR

10.4.1 PROXIMAL ULNA REPLACEMENT

10.4.2 DISTAL HUMERUS REPLACEMENT

10.5 CUSTOM MADE REPLACEMENTS

11 GLOBAL ENDOPROSTHESIS MARKET BY FINGER/HAND

11.1 OVERVIEW

11.2 TOTAL WRIST PROTHESIS

11.3 PIP FINGER PROSTHESIS

11.4 MCP FINGER PROSTHESIS

11.4.1 CARPOMETACARPAL JOINT PROSTHESIS

11.4.2 OTHERS

12 GLOBAL ENDOPROSTHESIS MARKET BY ANKLE/FOOT

12.1 OVERVIEW

12.2 TOTAL ANKLE

12.3 GREAT TOE IMPLANT

13 GLOBAL ENDOPROSTHESIS MARKET, BY REGION

13.1 OVERVIEW

13.2 NORTH AMERICA

13.2.1 US

13.2.2 CANADA

13.2.3 MEXICO

13.3 SOUTH AMERICA

13.3.1 ARGENTINA

13.3.2 BRAZIL

13.3.3 COLOMBIA

13.3.4 PERU

13.3.5 CHILE

13.3.6 ECUADOR

13.3.7 REST OF SOUTH AMERICA

13.4 EUROPE

13.4.1 GERMANY

13.4.2 AUSTRIA

13.4.3 SWISS

13.4.4 FINLAND

13.4.5 DENMARK

13.4.6 NORWAY

13.4.7 SWEDEN

13.4.8 BELGIUM

13.4.9 FRANCE

13.4.10 NETHERLANDS

13.4.11 GREAT BRITAIN

13.4.12 CZECHIA

13.4.13 ITALIA

13.4.14 SPAIN

13.4.15 HUNGARY

13.4.16 IRELAND

13.4.17 PORTUGAL

13.4.18 POLAND

13.4.19 RUSSIA

13.4.20 ROMANIA

13.4.21 TURKEY

13.4.22 REST OF EUROPE

13.5 ASIA-PACIFIC

13.5.1 CHINA

13.5.2 JAPAN

13.5.3 INDIA

13.5.4 AUSTRALIA

13.5.5 SOUTH KOREA

13.5.6 TAIWAN

13.5.7 NEW ZEALAND

13.5.8 REST OF ASIA-PACIFIC

13.6 MIDDLE EAST & AFRICA

13.6.1 SAUDI ARABIA

13.6.2 UAE

13.6.3 EGYPT

13.6.4 ISRAEL

13.6.5 SOUTH AFRICA

13.6.6 SYRIA

13.6.7 REST OF MEA

14 COMPETITIVE LANDSCAPE

14.1 COMPETITIVEOVERVIEW

14.2 MAJOR PLAYERS IN THE GLOBAL ENDOPROSTHESIS MARKET

14.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL ENDOPROSTHESIS MARKET

14.4 COMPETITIVE BENCHMARKING

14.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ENDOPROSTHESIS MARKET

14.6 KEY DEVELOPMENT ANALYSIS

14.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

14.7.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES

14.7.2 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES

14.8 MAJOR PLAYERS FINANCIAL MATRIX

14.8.1 REVENUE OF MAJOR PLAYERS

14.8.2 R&D EXPENDITURE

15 COMPANY PROFILES

15.1 JOHNSON & JOHNSON SERVICES, INC.

15.1.1 COMPANY OVERVIEW

15.1.2 FINANCIAL OVERVIEW

15.1.3 PRODUCTS/SERVICES OFFERED

15.1.4 KEY DEVELOPMENTS

15.1.5 SWOT ANALYSIS

15.1.6 KEY STRATEGIES

15.2 ZIMMER BIOMET HOLDINGS INC.

15.2.1 COMPANY OVERVIEWS

15.2.2 FINANCIAL OVERVIEW

15.2.3 PRODUCTS/SERVICES OFFERED

15.2.4 KEY DEVELOPMENTS

15.2.5 SWOT ANALYSIS

15.2.6 KEY STRATEGIES

15.3 STRYKER

15.3.1 COMPANY OVERVIEW

15.3.2 FINANCIAL OVERVIEW

15.3.3 PRODUCTS/SERVICES OFFERED

15.3.4 KEY DEVELOPMENTS

15.3.5 SWOT ANALYSIS

15.3.6 KEY STRATEGIES

15.4 SMITH AND NEPHEW

15.4.1 COMPANY OVERVIEW

15.4.2 FINANCIAL OVERVIEW

15.4.3 PRODUCTS/SERVICES OFFERED

15.4.4 KEY DEVELOPMENTS

15.4.5 SWOT ANALYSIS

15.4.6 KEY STRATEGIES

15.5 WALDEMAR LINK GMBH & CO. KG

15.5.1 COMPANY OVERVIEW

15.5.2 FINANCIAL OVERVIEW

15.5.3 PRODUCTS/SERVICES OFFERED

15.5.4 KEY DEVELOPMENTS

15.5.5 SWOT ANALYSIS

15.5.6 KEY STRATEGIES

15.6 LIMACORPORATE SPA.

15.6.1 COMPANY OVERVIEW

15.6.2 FINANCIAL OVERVIEW

15.6.3 PRODUCTS/SERVICES OFFERED

15.6.4 KEY DEVELOPMENTS

15.6.5 SWOT ANALYSIS

15.6.6 KEY STRATEGIES

15.7 CORIN LTD

15.7.1 COMPANY OVERVIEW

15.7.2 FINANCIAL OVERVIEW

15.7.3 PRODUCTS OFFERED

15.7.4 KEY DEVELOPMENTS

15.7.5 SWOT ANALYSIS

15.7.6 KEY STRATEGIES

15.8 PETER BREHM GMBH

15.8.1 COMPANY OVERVIEW

15.8.2 FINANCIAL OVERVIEW

15.8.3 PRODUCTS OFFERED

15.8.4 KEY DEVELOPMENTS

15.8.5 SWOT ANALYSIS

15.8.6 KEY STRATEGIES

15.9 MATHYS LTD BETTLACH

15.9.1 COMPANY OVERVIEW

15.9.2 FINANCIAL OVERVIEW

15.9.3 PRODUCTS OFFERED

15.9.4 KEY DEVELOPMENTS

15.9.5 SWOT ANALYSIS

15.9.6 KEY STRATEGIES

15.10 B. BRAUN MELSUNGEN AG

15.10.1 COMPANY OVERVIEW

15.10.2 FINANCIAL OVERVIEW

15.10.3 PRODUCTS OFFERED

15.10.4 KEY DEVELOPMENTS

15.10.5 SWOT ANALYSIS

15.10.6 KEY STRATEGIES

15.11 MEDACTA INTERNATIONAL SA

15.11.1 COMPANY OVERVIEW

15.11.2 FINANCIAL OVERVIEW

15.11.3 PRODUCTS/SERVICES OFFERED

15.11.4 KEY DEVELOPMENTS

15.11.5 SWOT ANALYSIS

15.11.6 KEY STRATEGIES

15.12 EXACTECH, INC.

15.12.1 COMPANY OVERVIEW

15.12.2 FINANCIAL OVERVIEW

15.12.3 PRODUCTS OFFERED

15.12.4 KEY DEVELOPMENTS

15.12.5 SWOT ANALYSIS

15.12.6 KEY STRATEGIES

15.13 MICROPORT ORTHOPEDICS, INC.

15.13.1 COMPANY OVERVIEW

15.13.2 FINANCIAL OVERVIEW

15.13.3 PRODUCTS OFFERED

15.13.4 KEY DEVELOPMENTS

15.13.5 SWOT ANALYSIS

15.13.6 KEY STRATEGIES

15.14 TIPSAN

15.14.1 COMPANY OVERVIEW

15.14.2 FINANCIAL OVERVIEW

15.14.3 PRODUCTS OFFERED

15.14.4 KEY DEVELOPMENTS

15.14.5 SWOT ANALYSIS

15.14.6 KEY STRATEGIES

15.15 BAUMER SA.

15.15.1 COMPANY OVERVIEW

15.15.2 FINANCIAL OVERVIEW

15.15.3 PRODUCTS OFFERED

15.15.4 KEY DEVELOPMENTS

15.15.5 SWOT ANALYSIS

15.15.6 KEY STRATEGIES

15.16 IMPOL

15.16.1 COMPANY OVERVIEW

15.16.2 FINANCIAL OVERVIEW

15.16.3 PRODUCTS OFFERED

15.16.4 KEY DEVELOPMENTS

15.16.5 SWOT ANALYSIS

15.16.6 KEY STRATEGIES

15.17 GROUPE LEPINE

15.17.1 COMPANY OVERVIEW

15.17.2 FINANCIAL OVERVIEW

15.17.3 PRODUCTS OFFERED

15.17.4 KEY DEVELOPMENTS

15.17.5 SWOT ANALYSIS

15.17.6 KEY STRATEGIES

15.18 CONFORMIS

15.18.1 COMPANY OVERVIEW

15.18.2 FINANCIAL OVERVIEW

15.18.3 PRODUCTS OFFERED

15.18.4 KEY DEVELOPMENTS

15.18.5 SWOT ANALYSIS

15.18.6 KEY STRATEGIES

15.19 DJO

15.19.1 COMPANY OVERVIEW

15.19.2 FINANCIAL OVERVIEW

15.19.3 PRODUCTS OFFERED

15.19.4 KEY DEVELOPMENTS

15.19.5 SWOT ANALYSIS

15.19.6 KEY STRATEGIES

15.20 IMPLANTCAST

15.20.1 COMPANY OVERVIEW

15.20.2 FINANCIAL OVERVIEW

15.20.3 PRODUCTS OFFERED

15.20.4 KEY DEVELOPMENTS

15.20.5 SWOT ANALYSIS

15.20.6 KEY STRATEGIES

16 APPENDIX

16.1 REFERENCES

16.2 RELATED REPORTS